These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
412 related articles for article (PubMed ID: 33870705)
1. Impact of Oral Anticoagulation Therapy Versus Left Atrial Appendage Occlusion on Cognitive Function and Quality of Life in Patients With Atrial Fibrillation. Mohanty S; Mohanty P; Trivedi C; Assadourian J; Mayedo AQ; MacDonald B; Della Rocca DG; Gianni C; Horton R; Al-Ahmad A; Bassiouny M; Burkhardt JD; Di Biase L; Gurol ME; Natale A J Am Heart Assoc; 2021 May; 10(9):e019664. PubMed ID: 33870705 [TBL] [Abstract][Full Text] [Related]
2. Lower rate of major bleeding in very high risk patients undergoing left atrial appendage occlusion: A propensity score-matched comparison with direct oral anticoagulant. Magnocavallo M; Della Rocca DG; Vetta G; Mohanty S; Gianni C; Polselli M; Rossi P; Parlavecchio A; Fazia MV; Guarracini F; De Vuono F; Bisignani A; Pannone L; Raposeiras-Roubín S; Lochy S; Cauti FM; Burkhardt JD; Boveda S; Sarkozy A; Sorgente A; Bianchi S; Chierchia GB; de Asmundis C; Al-Ahmad A; Di Biase L; Horton RP; Natale A Heart Rhythm; 2024 Aug; 21(8):1267-1276. PubMed ID: 38246567 [TBL] [Abstract][Full Text] [Related]
3. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN. Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282 [TBL] [Abstract][Full Text] [Related]
4. Left atrial appendage occlusion in recurrent ischaemic stroke, a multicentre experience. Galloo X; Carmeliet T; Prihadi EA; Lochy S; Scott B; Verheye S; Schoors D; Vermeersch P Acta Clin Belg; 2022 Apr; 77(2):255-260. PubMed ID: 32951514 [TBL] [Abstract][Full Text] [Related]
5. Left Atrial Appendage Occlusion as Adjunctive Therapy to Anticoagulation for Stroke Recurrence. Freixa X; Cruz-González I; Regueiro A; Nombela-Franco L; Estévez-Loureiro R; Ruiz-Salmerón R; Bethencourt A; Gutiérrez-García H; Fernández-Díaz JA; Moreno-Samos JC; Jiménez-Quevedo P; Martin-Yuste V; Arnold R; Millan X; Asmarats L; Ronquillo M; Agudelo-Montañez VH; López-Mínguez JR; Goicolea J; Pérez de Prado A; Arzamendi D J Invasive Cardiol; 2019 Aug; 31(8):212-216. PubMed ID: 31088992 [TBL] [Abstract][Full Text] [Related]
6. Association Between Left Atrial Appendage Occlusion and Readmission for Thromboembolism Among Patients With Atrial Fibrillation Undergoing Concomitant Cardiac Surgery. Friedman DJ; Piccini JP; Wang T; Zheng J; Malaisrie SC; Holmes DR; Suri RM; Mack MJ; Badhwar V; Jacobs JP; Gaca JG; Chow SC; Peterson ED; Brennan JM JAMA; 2018 Jan; 319(4):365-374. PubMed ID: 29362794 [TBL] [Abstract][Full Text] [Related]
7. Thromboembolic events and need for anticoagulation therapy following left atrial appendage occlusion in patients with electrical isolation of the appendage. Gadiyaram VK; Mohanty S; Gianni C; Trivedi C; Al-Ahmad A; Burkhardt DJ; Gallinghouse JG; Hranitzky PM; Horton RP; Sanchez JE; Della Rocca DG; Di Biase L; Price MJ; Couts L; Gibson D; Natale A J Cardiovasc Electrophysiol; 2019 Apr; 30(4):511-516. PubMed ID: 30623500 [TBL] [Abstract][Full Text] [Related]
9. COMPARE LAAO: Rationale and design of the randomized controlled trial "COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at high stroke risk and ineligible to use oral anticoagulation therapy". Huijboom M; Maarse M; Aarnink E; van Dijk V; Swaans M; van der Heijden J; IJsselmuiden S; Folkeringa R; Blaauw Y; Elvan A; Stevenhagen J; Vlachojannis G; van der Voort P; Westra S; Chaldoupi M; Khan M; de Groot J; van der Kley F; van Mieghem N; van Dijk E; Dijkgraaf M; Tijssen J; Boersma L Am Heart J; 2022 Aug; 250():45-56. PubMed ID: 35537503 [TBL] [Abstract][Full Text] [Related]
10. Clinical Outcomes Associated With Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulation in Atrial Fibrillation. Nielsen-Kudsk JE; Korsholm K; Damgaard D; Valentin JB; Diener HC; Camm AJ; Johnsen SP JACC Cardiovasc Interv; 2021 Jan; 14(1):69-78. PubMed ID: 33413867 [TBL] [Abstract][Full Text] [Related]
11. Left atrial appendage occlusion for stroke despite oral anticoagulation (resistant stroke). Results from the Amplatzer Cardiac Plug registry. Cruz-González I; González-Ferreiro R; Freixa X; Gafoor S; Shakir S; Omran H; Berti S; Santoro G; Kefer J; Landmesser U; Nielsen-Kudsk JE; Kanagaratnam P; Nietlispach F; Gloekler S; Aminian A; Danna P; Rezzaghi M; Stock F; Stolcova M; Paiva L; Costa M; Millán X; Ibrahim R; Tichelbäcker T; Schillinger W; Park JW; Sievert H; Meier B; Tzikas A Rev Esp Cardiol (Engl Ed); 2020 Jan; 73(1):28-34. PubMed ID: 31036510 [TBL] [Abstract][Full Text] [Related]
12. Comparison of CHADS2 and CHA2DS2-VASC anticoagulation recommendations: evaluation in a cohort of atrial fibrillation ablation patients. Winkle RA; Mead RH; Engel G; Kong MH; Patrawala RA Europace; 2014 Feb; 16(2):195-201. PubMed ID: 24036378 [TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of left atrial appendage occlusion versus direct oral anticoagulation in patients with atrial fibrillation and prior ischemic stroke: A propensity-score matched study. Korsholm K; Valentin JB; Damgaard D; Diener HC; Camm AJ; Landmesser U; Hildick-Smith D; Johnsen SP; Nielsen-Kudsk JE Int J Cardiol; 2022 Sep; 363():56-63. PubMed ID: 35780932 [TBL] [Abstract][Full Text] [Related]
14. Use of left atrial appendage occlusion among older cardiac surgery patients with preoperative atrial fibrillation: a national cohort study. Friedman DJ; Gaca JG; Wang T; Malaisrie SC; Holmes DR; Piccini JP; Suri RM; Mack MJ; Badhwar V; Jacobs JP; Peterson ED; Chow SC; Matthew Brennan J J Interv Card Electrophysiol; 2020 Apr; 57(3):399-407. PubMed ID: 30712076 [TBL] [Abstract][Full Text] [Related]
15. Percutaneous left atrial appendage occlusion and risk of stroke, hospitalized bleeding and death in Medicare beneficiaries. Wang W; Chen LY; Walker RF; Alonso A; Norby FL; Lakshminarayan K; Lutsey PL Pharmacoepidemiol Drug Saf; 2024 Apr; 33(4):e5786. PubMed ID: 38565524 [TBL] [Abstract][Full Text] [Related]
16. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage. Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Mazzone P; Foley D; Grygier M; Sievert H; De Potter T; Vireca E; Stein K; Bergmann MW; Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e006841. PubMed ID: 30939908 [TBL] [Abstract][Full Text] [Related]
17. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981 [TBL] [Abstract][Full Text] [Related]
18. Safety and feasibility of combined atrial fibrillation ablation and left atrial appendage occlusion after left atrial appendage electrical isolation. Kita K; Carlson S; Huntsinger M; Tun H; Sohn J; Doshi RN J Interv Card Electrophysiol; 2020 Jan; 57(1):43-55. PubMed ID: 31377973 [TBL] [Abstract][Full Text] [Related]